Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early stage research papers that have not been peer-reviewed. The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact email@example.com.
Integrative Analysis of Multi-omics Data Reveals AP-1 Is a Key Regulator in Intrahepatic Cholangiocarcinoma
24 Pages Posted: 15 May 2020More...
Intrahepatic cholangiocarcinoma (ICC) is a malignant tumor with poor prognosis. Currently, its mechanism of pathogenesis remains elusive. In this study, we employed integrative -omics approaches (RNA-seq, ChIP-seq, and MNase-seq) to interrogate the epigenome in ICC. The results of ChIP-seq, differential gene expression, and MNase-seq analyses suggested that ICC cell lines exhibit less histone modification of cancer-related genes compared with a normal cell line. The region of different histone modification patterns is enrichment in sites of AP-1 motif. Subsequent analysis showed that ICC had different nucleosome occupancy in differentially expressed genes compared to a normal cell line. Furthermore, we found that AP-1 plays a key role in ICC and regulates ICC-related genes through its AP-1 binding site. This study is the first report showing the global features of histone modification, transcript, and nucleosome profiles in ICC; we also show that the transcription factor AP-1 might be a key target gene in ICC.
Funding Statement: This work was supported by granted from the National Natural Science Foundation of China (No. 81071990, No. 81641110); Science and Technology Program of Guangzhou, China (No. 201707010305); Youth Science Foundation of Guangdong Second Provincial General Hospital (No. YQ2016-001).
Declaration of Interests: The authors declare that they have no conflicts of interest.
Keywords: Intrahepatic cholangiocarcinoma, Histone modification, Nucleosome positioning, Data analysis, AP-1
Suggested Citation: Suggested Citation